Recent studies show that FDA-approved antiretroviral FTC/TAF may slow aging by reducing retrotransposon activity, highlighting a promising gerotherapeutic approach with broad accessibility. Groundbrea...
A Danish register-based study reveals flu vaccination reduces heart attack and stroke risk by curbing inflammation, offering a key strategy for aging populations and preventive health. Recent data sho...
Recent studies show aging clocks integrating clinical and microbiome data can predict biological age, enabling personalized anti-aging interventions through tailored diets and therapies. Advancements ...
Recent studies show a strong link between periodontal disease and cognitive decline, with severe gum inflammation increasing dementia risk by up to 50%, highlighting preventive oral care. Groundbreaki...
Recent studies show micro- and nanoplastics are found in human tissues, potentially speeding up aging via oxidative stress and inflammation, with gaps in human data needing urgent research. New resear...
Recent research demonstrates how reduced protein intake promotes white fat browning through gut bacteria interactions, mimicking calorie restriction effects for potential obesity and aging therapies. ...
Recent studies show α-eleostearic acid and its methyl ester induce ferroptosis in senescent cells, reducing inflammation and improving muscle function in aged mice without toxicity, with clinical tri...
Senolytic and senomorphic therapies, including Rubedo’s RLS-1496 in Phase 1 trials, target senescent cells to treat aging diseases, boosted by AI-driven discovery and rising investment. New seno...
Senolytic and senomorphic therapies are advancing with compounds like RLS-1496 and α-ESA-me targeting senescent cells. Experts highlight challenges in biomarkers and safety, pushing for personalized ...
Recent breakthroughs in senolytic and senomorphic therapies, including polyunsaturated lipids inducing ferroptosis, are advancing clinical trials for age-related diseases, with a focus on safety and b...
